These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 22868241)
1. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database. Yan W; Christos P; Nori D; Chao KS; Ravi A Am J Clin Oncol; 2013 Dec; 36(6):552-7. PubMed ID: 22868241 [TBL] [Abstract][Full Text] [Related]
2. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis. McCammon R; Finlayson C; Schwer A; Rabinovitch R Cancer; 2008 Aug; 113(4):683-9. PubMed ID: 18543316 [TBL] [Abstract][Full Text] [Related]
3. Postmastectomy radiation therapy for T3N0: a SEER analysis. Johnson ME; Handorf EA; Martin JM; Hayes SB Cancer; 2014 Nov; 120(22):3569-74. PubMed ID: 24985911 [TBL] [Abstract][Full Text] [Related]
4. Postmastectomy radiation and survival in older women with breast cancer. Smith BD; Haffty BG; Hurria A; Galusha DH; Gross CP J Clin Oncol; 2006 Oct; 24(30):4901-7. PubMed ID: 17050874 [TBL] [Abstract][Full Text] [Related]
5. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database. Yu JB; Wilson LD; Dasgupta T; Castrucci WA; Weidhaas JB Cancer; 2008 Jul; 113(1):38-47. PubMed ID: 18442108 [TBL] [Abstract][Full Text] [Related]
6. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Fields EC; DeWitt P; Fisher CM; Rabinovitch R Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917 [TBL] [Abstract][Full Text] [Related]
7. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Shirvani SM; Pan IW; Buchholz TA; Shih YC; Hoffman KE; Giordano SH; Smith BD Cancer; 2011 Oct; 117(20):4595-605. PubMed ID: 21710653 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers. Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis. Chen J; Wu X; Christos P; Yan W; Ravi A Clin Breast Cancer; 2018 Oct; 18(5):e967-e973. PubMed ID: 29914691 [TBL] [Abstract][Full Text] [Related]
10. Postmastectomy radiation therapy in T3 node-negative breast cancer. Elmore L; Deshpande A; Daly M; Margenthaler JA J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852 [TBL] [Abstract][Full Text] [Related]
11. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937 [TBL] [Abstract][Full Text] [Related]
12. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176 [TBL] [Abstract][Full Text] [Related]
13. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546 [TBL] [Abstract][Full Text] [Related]
14. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis. Abrams MJ; Koffer PP; Wazer DE; Hepel JT Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158 [TBL] [Abstract][Full Text] [Related]
15. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998 [TBL] [Abstract][Full Text] [Related]
16. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J; J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604 [TBL] [Abstract][Full Text] [Related]
18. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death. Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis. Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343 [TBL] [Abstract][Full Text] [Related]
20. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]